# Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)

> **NCT07671157** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Maryanne Makredes Senna** · enrollment: 30 (estimated)

## Conditions studied

- Frontal Fibrosing Alopecia

## Interventions

- **DRUG:** Delgocitinib

## Key facts

- **NCT ID:** NCT07671157
- **Lead sponsor:** Maryanne Makredes Senna
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-10
- **Primary completion:** 2027-10-10
- **Final completion:** 2027-10-10
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671157, "Trial of Delgocitinib 20 mg/g Cream in Subjects With Frontal Fibrosing Alopecia (FFA)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07671157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*